Faron Pharmaceuticals
Turku, Finland· Est. 1997
Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON) is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. We aim to address unmet medical needs in cancer and improve patient lives.
Private Company
Total funding raised: $55M
About
Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON) is a global, clinical-stage biopharmaceutical company, focused on creating innovative cancer treatments that leverage the patient’s own immune system. We aim to address unmet medical needs in cancer and improve patient lives.
Biologics
Pipeline
1010 drugs in pipeline1 in Phase 3
| Drug | Indication | Stage | Watch |
|---|---|---|---|
| Interferon beta-1a + Placebo | Respiratory Distress Syndrome, Adult | Phase 3 | |
| Interferon Beta-1A + Placebo | Preventive Medicine | Phase 2 | |
| IFN beta-1a + Dexamethasone | Covid19 | Phase 2 | |
| bexmarilimab | Carcinoma, Renal Cell | Phase 1/2 | |
| Interferon Beta-1A | Recurrent B Acute Lymphoblastic Leukemia | Phase 1/2 |
Funding History
3Total raised:$55M
Debt$10MMay 15, 2022
PIPE$20MSep 15, 2020
IPO$25MDec 15, 2015